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Abstract
Objectives: This study was designed to investigate the association of gender, fibre type composition, and anaerobic
performance with the basal skeletal muscle signalling cascades regulating muscle phenotype. Design: Muscle biopsies
were obtained from 25 men and 10 women all young and healthy. Methods. Protein phosphorylation of Thr172AMPKα,
Ser221ACCβ, Thr286CaMKII as well as total protein abundance of PGC-1α, SIRT1, and CnA were measured by Western
blot and anaerobic performance by the Wingate test. Results: Percent type I myosin heavy chain (MHC I) was lower in
men (37.1 ± 10.4 vs. 58.5 ± 12.5, P< .01). Total, free testosterone and free androgen index were higher in men (11.5,
36.6 and 40.6 fold, respectively, P< .01). AMPKα phosphorylation was 2.2-fold higher in men compared to women (P
< .01). Total Ser221ACCβ and Thr286CaMKII fractional phosphorylation tended to be higher in men (P= .1). PGC1-α
and SIRT1 total protein expression was similar in men and women, whereas CnA tended to be higher in men (P= .1).
Basal AMPKα phosphorylation was linearly related to the percentage of MHC I in men (r= 0.56; P< .01), but not in
women. No association was observed between anaerobic performance and basal phosphorylations in men and women,
analysed separately. Conclusion: In summary, skeletal muscle basal AMPKα phosphorylation is higher in men compared
to women, with no apparent effect on anaerobic performance.
Keywords: AMPK, muscle signalling, muscle phenotype, gender, anaerobic performance
Introduction
Human skeletal muscle is composed of different fibre
types (I, IIa, and IIx) with distinctive functional and
metabolic capacities. Predominantly type I fibre
muscles have a higher oxidative capacity, whereas a
high proportion of type II muscle fibres or myosin
heavy chain (MHC) II is associated with high levels
of muscle power and strength (Aagaard & Andersen,
1998). Some studies point that women have a slightly
higher percentage of type I muscle fibres in their
vastus lateralis than men (Richter & Ruderman,
2009). However, little is known about the molecular
mechanisms that could explain a sex dimorphism in
skeletal muscle phenotypes and its association with
anaerobic performance in humans.
The contractile properties of muscle fibres are
dependent on the variable expression of proteins
involved in Ca2+ signalling and handling (Berchtold,
Brinkmeier, & Muntener, 2000). Among these,
AMP-activated protein kinase (AMPK), the tran-
scriptional cofactor of the proliferator-activated
receptor gamma (PPARγ) coactivator 1α (PGC-1α),
its upstream regulator silent information regulator
proteins (SIRTs), calcineurin (CnA), and the Ca2+/
calmodulin-dependent protein kinase II (CaMKII)
could explain a sexual dimorphism in muscle
phenotypes.
AMPK acts as an “energy sensor” of the cell, and is
activated by phosphorylation of its threonine residue
172 (Thr172) when there is an increase in the
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intracellular AMP/ATP ratio. During muscle con-
traction, the rate of ATP turnover increases and
AMPK phosphorylation (pAMPK) can be elicited
by both moderate (Roepstorff et al., 2006) and
high-intensity exercises (Guerra et al., 2010;
Morales-Alamo et al., 2012, 2013). AMPK also
induces higher hexokinase and PGC-1α levels, sti-
mulating mitochondrial biogenesis and fibre type
switching towards type I fibres (Richter & Ruderman,
2009; Steinberg & Jorgensen, 2007). Thus, AMPK is
believed to be stimulated in the skeletal muscle by the
adipocyte-derived hormone leptin (Steinberg & Jor-
gensen, 2007). Our laboratory has demonstrated
that women have higher protein abundance of the sig-
nalling isoform of the leptin receptor in muscle than
men (Guerra et al., 2008), likely due to a direct
stimulation by oestrogens (Fu, Maher, Hamadeh,
Ye, & Tarnopolsky, 2009). Whether women have
higher basal muscle pAMPK levels compared to
men remains to be elucidated.
Free intracellular Ca2+ concentration is another
potent stimulator of signalling pathways mediating
muscle fibre type plasticity. Free Ca2+ binds to cal-
modulin, which activates CnA and CaMKII. CnA
dephosphorylates nuclear factor of activated T
cells and regulates slow fibre gene expression
(Chin, 2005). Finally, SIRTs are NAD+-dependent
deacetylases which are sensitive to the cellular
redox state and are another “energy sensor” of
the cell. SIRT1 regulates insulin sensitivity, metab-
olism, and mitochondrial biogenesis through deace-
tylation of PGC-1α (Finkel, Deng, & Mostoslavsky,
2009). SIRT1 modulates the expression of several
genes involved in lipid metabolism (Finkel et al.,
2009), however, no data are available comparing
skeletal muscle SIRT1 protein content in men
and women.
Between-sex differences in basal signalling may
account for differences in metabolic and mechanical
capacities of skeletal muscle and, hence, sprint per-
formance. Interestingly, although peak power per
muscle mass is similar in men and women, men
have greater anaerobic capacity (Fuentes et al.,
2012). Thus, we hypothesised that basal levels of
AMPKα phosphorylation, as well as the signalling
components promoting increased expression of type
I muscle fibres will be increased in women compared
to men. We also hypothesised that basal skeletal
muscle CaMKII phosphorylation would be greater
in men than women.
Therefore, the main aims of this study were to
determine if sex differences in skeletal muscle fibre
type are associated with differences in AMPK, its
downstream target acetyl-CoA carboxylase (ACC)
and CaMKII phosphorylation, or to CnA, SIRT1,
and PGC-1α protein levels. A secondary aim was to
determine if AMPK, ACC, and CaMKII phosphoryl-
ation, or CnA, SIRT1, and PGC-1α protein
expression are associated with sprint performance.
Such an association could indicate that the involved
protein or transcription factor may play a role in the
phenotypic changes associated with greater or lower
anaerobic energy production.
Material and methods
Materials
The complete protease inhibitor cocktail was
obtained from Roche Diagnostics (Mannheim,
Germany). All the primary antibodies used were
from Cell Signalling Technology (Danvers, MA,
USA) except for the polyclonal rabbit antiphospho-
ACC (Ser79) antibody that was purchased from
Upstate Biotechnology (Lake Placid, NY, USA),
the monoclonal mouse anticalcineurin α and β anti-
body from Sigma-Aldrich (St Louis, MO, USA),
and the polyclonal rabbit antiphospho-Ca2+/calmo-
dulin-dependent protein kinase II (Thr177) antibody
from Santa Cruz Biotechnology (Santa Cruz, CA,
USA). The secondary horseradish peroxidase
(HRP)-conjugated goat anti-rabbit and donkey anti-
mouse antibodies were from Jackson Immuno
Research (West Grove, PA, USA). The Hybond-P
transfer membranes and the enhanced chemilumi-
nescence (ECL) plus Western Blotting Detection
System were from Amersham Biosciences (Little
Chalfont, Buckinghamshire, UK). The ChemiDoc
XRS System and the image analysis software Quan-
tity One
©
were obtained from Bio-Rad Laboratories
(Hemel Hempstead, Hertfordshire, UK).
Subjects
Thirty-five physical education students agreed to par-
ticipate in this investigation (Table I). Before volun-
teering, subjects were given full oral and written
information about the procedures of the study and
possible risks associated with participation. Exclusion
criteria included a history of endocrine, renal, meta-
bolic diseases, smoking, or drug abuse. None of the
subjects taking part in the study had any medical con-
dition known to affect fat metabolism or eating dis-
orders. All women were eumenorrheic, and four of
themwere taking contraceptive pills. None of our vol-
unteers accomplished exclusion criteria. The study
was performed in accordance with the Helsinki
Declaration of 1975, as last modified in 2000, regard-
ing the conduct of clinical research, and was
approved by the Ethical Committee of the University
of Las Palmas de Gran Canaria.
2 A. Guadalupe-Grau et al.
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Study design
All subjects were resting during the experimental pro-
cedures and requested to refrain from strenuous exer-
cise, caffeine, or alcohol drinks, 24 h prior to
experimental days. On the first experimental day sub-
jects arrived to our laboratory at 8:00 am and physical
performance and body composition measurements
were done under fasting conditions. On a separate
day, subjects reported to the laboratory at 8–9 h am
after an overnight fast. Following a 10 min resting
period in a supine resting position 20 ml blood
samples were taken from an antecubital vein. The
blood samples were allowed to clot at room tempera-
ture for 10 min in tubes containing the clot activation
gel (Vacutainer®, Becton Dickinson, France) and
then were centrifuged at 3500 rpm during 15 min,
and a set temperature of 4°C (Allegra 21R,
Beckman Instruments, Fullerton, CA). The serum
obtained was separated and frozen at −80°C for later
analysis. Next, a needle muscle biopsy specimen was
obtained from themiddle section of the vastus lateralis
muscle under local anaesthesia with suction, andmild
pressure on the lateral aspect of the thigh. The muscle
samples were immediately frozen in liquid nitrogen
for Western blotting and MHCs determination and
stored at −80°C. The time needed to obtain and
freeze the muscle biopsies was below 30 s in all cases.
Body composition and anaerobic performance
Body composition was determined by whole-body
dual-energy X-ray absorptiometry measurements
(Hologic QDR-1500, Hologic Corp., software
version 7.10, Waltham, MA) as described elsewhere
(Calbet, Dorado, Diaz-Herrera, & Rodriguez-Rodri-
guez, 2001). Anaerobic performance was measured
by a 30 s Wingate test as reported elsewhere
(Ponce-Gonzalez et al., 2012).
MHCs determination
MHC analyses were performed on the muscle biop-
sies using sodium dodecyl sulfate polyacrylamide
gel electrophoresis (SDS-PAGE), as reported by
Larsson, Andersen, Kadi, Bjork, and Gerdle
(2002). After protein extraction using urea buffer,
between 2 and 12 µl of the myosin-containing
samples were loaded on SDS-PAGE. Gels were run
at 70 V for 43 h at 4°C. Subsequently, the gels were
Coomassie stained, and MHC isoform bands (I,
IIa, and IIx) were determined based on known
migration patterns and quantified with the image
analysis software Quantity One from Bio-Rad Lab-
oratories (Hemel, Hempstead, Hertfordshire, UK).
ATPase histochemistry
Serial sections (8 μm) of the muscle biopsy samples
from 20 males and 7 females due to sample limit-
ations were cut in a cryostat (−20°C), and routine
ATPase histochemistry analysis was performed after
preincubation at pH of 4.37, 4.60, and 10.30 as pre-
viously reported (Sanchis-Moysi et al., 2010). Fibre
typing (I, IIa, and IIx) and cross sectional areas
(CSA) were determined using the specialised soft-
ware Visilog (Noesis, France).
Total protein extraction, electrophoresis, and Western
blot analysis
Muscle protein extracts were prepared as described
previously (Guerra et al., 2007), and total protein
Table I. Physical characteristics, anaerobic performance,
hormonal concentrations, and muscle morphology (mean ± SD).
Men (n= 25)
Women
(n= 10)
Age (year) 24.1 ± 3.4 25.3 ± 4.0
Height (cm) 177.6 ± 6.2 160.7 ± 5.5∗
Body mass (kg) 78.6 ± 8.8 57.0 ± 6.7∗
Fat mass (%) 16.1 ± 7.0 29.1 ± 4.2∗∗
Anaerobic performance
Pmax (W) 1011.6 ± 125.9 586.4 ± 55.6∗
PmaxN (W/kg body mass) 13.0 ± 1.6 10.4 ± 1.2∗
PmaxN (W/kg lean
leg mass)
51.8 ± 6.2 50.5 ± 3.9
Pmean (W) 646.5 ± 84.9 348.8 ± 82.4∗
PmeanN (W/kg body
mass)
4.1 ± 0.6 3.0 ± 0.6∗
PmeanN (W/kg lean
leg mass)
46.4 ± 5.8 49.3 ± 3.3
Hormonal concentrations
Leptin (ng/ml) 4.1 ± 4.0 13.5 ± 5.9∗∗
FAI 69.1 ± 24.4 1.7 ± 2.1∗∗
FT (ng/ml) 0.11 ± 0.03 0.003 ± 0.003∗∗
TT (ng/ml) 4.6 ± 1.3 0.4 ± 0.2∗∗
SHBG (nmol/l) 25.4 ± 9.9 147.2 ± 98.4∗
β-Estradiol (pg/ml) 88.1 ± 88.7
Muscle morphology
Type I MHC (%) 42.0 ± 10.4 60.2 ± 12.5∗
Type IIa MHC (%) 42.3 ± 5.5 28.2 ± 10.6∗
Type IIx MHC (%) 21.8 ± 6.6 14.4 ± 5.2
Type I CSA (µm2) 4399.6 ± 1131.8 3308.8 ± 495.7∗
Type IIa CSA (µm2) 6067.2 ± 1571.5 3869.2 ± 490.9∗
Type IIx CSA (µm2) 5172.8 ± 1390.4 3439.6 ± 658.6∗
ATPase type I fibre (%) 42.4 ± 11.5 61.9 ± 4.1∗
ATPase type IIa fibre (%) 37.9 ± 7.6 25.9 ± 5.2∗
ATPase type IIx fibre (%) 13.5 ± 9.7 10.9 ± 5.0
Notes: Pmax, peak power output during the Wingate test; Pmean,
mean power output during the Wingate test; PmaxN, peak power
output during theWingate test relative to kilo gram of bodymass or
lean leg mass; PmeanN, mean power output during the Wingate test
relative to kilo gram of body mass or lean leg mass.
∗P< .05.
∗∗P< .01 compared to men.
Gender, AMPK and anaerobic performance 3
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content was quantified using the bicinchoninic acid
assay (Smith et al., 1985). Equal amounts (50 μg)
of each sample were subjected to immunoblotting
protocol as described previously (Guerra et al.,
2007). Separated gels (Bio-Rad Laboratories, Her-
cules, CA, USA) were loaded to detect the total
and phosphorylated forms of the target molecules.
To determine Thr172AMPKα, Ser221ACCβ, and
Thr286CaMKII levels, antibodies directed against
the phosphorylated and total form of these kinases
were used diluted in 5% bovine serum albumin in
tris-buffered saline with 0.1% Tween 20 (TBS-T)
(BSA-blocking buffer). To detect PGC-1α, CnA,
and SIRT1 total protein expression, membranes
were incubated with a polyclonal-specific anti
human PGC-1α, CnA, and SIRT1 antibodies
(diluted in BSA-blocking buffer).
To control for differences in loading and transfer
efficiency, the membranes were incubated with a
monoclonal mouse anti-alpha-tubulin antibody
diluted in TBS-T with 5% blotting grade blocker
non-fat dry milk (blotto-blocking buffer). No signifi-
cant changes were observed in alpha-tubulin protein
levels during the experiments (data not shown). Anti-
body-specific labelling was revealed by incubation
with a HRP-conjugated goat anti-rabbit antibody
(1:20,000) or a HRP-conjugated donkey anti-mouse
(1:10,000) antibody both diluted in blotto-blocking
buffer and visualised with the ECL chemilumines-
cence detection kit (Amersham Biosciences). Specific
bands were visualised using the ChemiDoc XRS
system (Bio-Rad Laboratories, Hercules, CA, USA)
and quantified by the image analysis program Quan-
tity one© (Bio-Rad Laboratories, Hercules, CA,
USA). The densitometry analysis was carried out
immediately before saturation of the immunosignal.
All proteins were measured in duplicate, and the vari-
ation coefficient was below 15%. Samples were
loaded as follows: men–men–women in each gel (15
wells) to reduce inter-gel variance between groups.
In addition, one muscle sample obtained from a
healthy young man was loaded as an internal
control on all gels to control for inter-gel variability.
Overall, the variation coefficient for the control
loaded in all gels was 12%. Data were represented
as immunostaining values obtained for the phos-
phorylated form of each kinase relative to those
obtained for respectively total form, or alpha-tubulin.
Hormonal assays
Serum leptin was determined by enzyme-linked
immunosorbent assay (ELx800 Universal Microplate
Reader, Bioteck Instruments Inc., Vermont, USA),
using reagent kits from Millipore (#EZHL-80SK,
Millipore EMD, Billerica, MA, USA) and following
the manufacturer’s instructions. The sensitivity of
the total leptin assays was 0.05 ng/ml. The intra-
assay coefficient variation was 3.8%, and the inter-
assay coefficient of variation was 4.4%.
Serum total testosterone (TT) and sex hormone-
binding globulin (SHBG) concentrations were
measured by a fully automated two-site, solid-
phase, chemiluminescent enzyme immunometric
assay (Immulite 2000®, Siemens Healthcare Diag-
nostics). Samples were processed interserially includ-
ing different batches, six calibrations and two control
levels for each sample series. The intra-assay coeffi-
cients of variation were 9.8% and 2.2%, respectively,
and the inter-assay coefficients of variation were
11.0% and 5.1%. Lower end sensitivity endpoints
were settled at 15 ng/dl and 0.02 nmol/l.
Free androgen index (FAI), as an estimation of
bioavailable testosterone, was calculated as described
by Ly and Handelsman (2005). Moreover, free tes-
tosterone (FT) concentration was estimated using
other procedures (Vermeulen, Verdonck, &
Kaufman, 1999). 17β-Oestradiol was measured by a
competitive electrochemiluminescence immunoassay
intended for use onModular Analytics analyzer E170
using E2 reagents (Roche/Hitachi, 03000079122,
Indianapolis, IN, USA). Results were determined
via a calibration curve with analytic sensitivity of
18.4 pmol/l. The intra-assay coefficient of variation
was 9.5%, and the inter-assay coefficient of variation
was 5.8%.
Statistical analysis
Variables were checked for normal distribution by
using the Shapiro-Wilks test and for equality of var-
iances with the Levene’s test. When necessary, the
analysis was done on logarithmically transformed
data. Unpaired t-tests were used to test between-
group differences. The relationship between variables
was determined using linear regression analysis. Cor-
relations were tested with the Pearson’s test. Values
are reported as the mean ± standard error of the
mean. P< 0.05 was considered significant. Statistical
analysis was performed using SPSS v. 15.0 for
Windows (SPSS Inc., Chicago, IL, USA).
Results
Gender differences in hormones, anaerobic
performance, and muscle morphology
Anthropometrics, body composition, hormone con-
centrations, anaerobic performance, and fibre
typing by both MHC type distribution and ATPase
staining, as well as fibre types CSA are reported in
Table I. Both genders were comparable in age, but
4 A. Guadalupe-Grau et al.
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women were smaller, had lower body mass and
higher percentage of body fat compared to men (all,
P< .01, Table I). Men reached a higher peak and
mean power output during the Wingate test than
women (P < .05, Table I). However, when account-
ing for the lean mass of the lower extremities, both
sexes achieved similar relative peak power values,
but the relative mean power output was greater in
men than women (Table I). Men had a higher per-
centage of type IIa, fibres, and lower proportion of
type I fibres, measured by both ATPase staining
and MHC electrophoresis, compared to women (all
P< .01, Table I). CSAs were higher in males in all
fibre types (all P< .05, Table I). Compared to men,
women had a higher serum concentration of leptin
(13.5 ± 5.9 vs. 4.1 ± 4.0 ng/ml, P< .01, Table I).
TT, FT, and FAI were 11.5, 36.6, and 40.6 fold
higher in men than women (all P < .01, Table I),
whereas SHBG was higher in women (25.4 ± 9.9 vs.
147.2 ± 98.4 nmol/l, P < .01, Table I).
Gender comparisons in basal skeletal muscle signalling
The basal Thr172AMPKα/Total AMPKα (fractional
phosphorylation of AMPKα) was twofold higher in
men than in women (2.3 ± 1.4 vs. 1.0 ± 0.5 a.u.,
respectively, P< .01; Figure 1, panel A). The total
amount of Thr172AMPKα protein was also higher
in men compared to women (5.7 ± 0.8 vs. 2.6 ± 0.4
a.u., P< .05). No significant between-sex differences
were observed in Ser221ACCβ/ACCβ phosphoryl-
ation (Figure 1, panel B), although total
Ser221ACCβ levels tended to be higher in men (0.8
± 0.1 vs. 0.5 ± 0.1 a.u., respectively, P = .08). Both
total Thr286CaMKII phosphorylation and
Thr286CaMKII/Total CaMKII tended to be higher
in men than women (0.8 ± 0.1 vs. 0.4 ± 0.1 and 2.5 ±
2.9 vs. 1.2 ± 1.3 a.u., respectively, P= .10; Figure 1,
panel C). No significant differences between sexes
were observed in the total amount of AMPKα,
ACCβ, and CaMKII. PGC-1α and SIRT1 total
protein expression was similar in both groups. CnA
tended to be higher in men than in women (P= .10,
Figure 2, panel A, B, and C).
Correlations
When all subjects were pooled together (n = 35), the
percentage of MHC IIa fibres was positively associ-
ated to basal Thr172AMPK/Total AMPKα (r= 0.39,
P< .05, Figure 3, panel B), as well as Thr286CaM-
KII/Total CaMKII (r = 0.34, P < .05).
Thr172AMPK/Total AMPKα and Thr286CaMKII/
Total CaMKIIα were also positively associated (r=
0.65, P< .01). Moreover, CnA was positively
Figure 1. (a) Levels of basal Thr172AMPKα phosphorylation to
total AMPKα (a.u.). (b) Levels of basal Ser221ACCβ phosphoryl-
ation to total ACCβ (a.u.). (c) Levels of basal Thr286CaMKII phos-
phorylation to total CaMKII (a.u.). Men (black bar) and women
(white bar). Data are means ± SD; ∗P< .01.
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associated with MHC IIx (r= 0.62, n = 22, P < .01).
Thr172AMPK/Total AMPKα was negatively associ-
ated with SIRT1 protein expression (r =−0.39,
P< .05). SIRT1 was positively associated with
PGC-1α protein expression (r= 0.64, P < .01), and
both SIRT1 and PGC-1α total protein expression
were negatively associated with MHC IIa (r=−0.45
and −0.47, respectively; P< .05).
Absolute peak power during the Wingate tests was
positively associated with basal Thr172AMPK/Total
AMPKα (Figure 3, panel C), total body lean mass,
lower extremities lean mass, the percentage of
MHC IIa and IIx, CSA I, IIa, and IIx, TT, and
FAI (r = 0.48, 0.85, 0.87, 0.81, 0.57, 0.55, 0.70,
0.61, and 0.90, respectively, all P< .05). Absolute
peak power during the Wingate tests was also nega-
tively associated with PGC-1α, SIRT1, MHC I,
serum leptin, and SHBG (r =−0.58, −0.75, −0.75,
−0.49, −0.84, all P < .05). These relationships were
maintained when peak power was normalised by the
lean mass of the lower extremities, except for basal
Thr172AMPK/Total AMPKα (all P < .05, Figure 3,
panel D).
When only men were taken into consideration for
the correlation analysis, the percentage of MHC I
was positively associated with basal Thr172AMPK/
Total AMPKα (r = 0.47, n = 25, P< .05, Figure 3,
panel A), as well as Thr286CaMKII/Total CaMKII
(r = 0.50, n = 25, P< .01). Thr172AMPK/Total
AMPKα and Thr286CaMKII/Total CaMKII were
also positively associated (r = 0.56, n = 25, P < .01).
Thr172AMPK/Total AMPKα was negatively associ-
ated with SIRT1 protein expression (r=−0.64, n =
25, P < .01). SIRT1 tended to be positively correlated
with PGC-1α protein expression (r = 0.35, n= 25,
P= .08).
Absolute peak power during the Wingate tests was
positively associated with lower extremities lean
mass, and tended to be to associated with the percen-
tage of MHC IIx (r = 0.45 and 0.44, P < .05 and
P= .08, n = 25 and n = 18, respectively). This
relationship reached significance when peak power
was normalised by the lean mass of the lower extremi-
ties (r = 0.68, n = 25, P< .01). No associations were
observed between either Pmax or PmaxN and basal
AMPK (Figure 3, panels C and D), ACC and
CaMKII fractional phosphorylations. No association
was observed between the lean mass of the lower
extremities and AMPK, ACC, and CaMKII frac-
tional phosphorylations. A tendency was observed
towards a positive association between PmaxN with
FT and FAI (r= 0.30 and 0.31 respectively, P= .1).
Leptin was strongly correlated with the percentage
of body fat (r= 0.91, P< .01, n= 25). Both FAI and
FT tended to be positively associated with
Ser221ACCβ/Total ACCβ (r= 0.36, P= .07, and r=
0.35, P= .08 respectively, n= 25), whereas only FAI
was significantly associated with absolute peak power
during the Wingate test (r= 0.44, P< .05, n= 25).
Figure 2. (a) Levels of basal SIRT1 to alpha-tubulin total protein
content (a.u.). (b) Levels of basal PGC1-α to tubulin-alpha total
protein content (a.u.). (c) Levels of basal CanA to alpha-tubulin
total protein content (a.u.). Men (black bar) and women (white
bar). Data are means ± SD; ∗P< .01.
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Discussion
In contrast to our hypothesis, the present study shows
that basal skeletal muscle Thr172AMPKα phos-
phorylation was twofold higher in men than in
women. This difference is remarkable if compared
to the two-to-six fold increase in pAMPK observed
after 30 s sprints (Fuentes et al., 2012; Guerra
et al., 2010; Morales-Alamo et al., 2013). Since
there was a positive association between Thr286CaM-
KII phosphorylation and Thr172AMPKα phosphoryl-
ation, and a tendency for a higher basal
Thr286CaMKII values in men compared to women,
basal differences in calcium-mediated signalling
could be the mechanisms explaining this sexual
dimorphism in Thr172AMPK phosphorylation.
There is some CaMKII activity at rest, which is
increased in response to oxidative stress, and con-
ditions increasing cytosolic Ca2+, like muscle con-
traction (Morales-Alamo et al., 2012, 2013). Given
the relatively smaller muscle mass and the higher
mechanical load, Ca2+ transients are expected to be
of higher amplitude and frequency in women.
However, increased Ca2+ transients could have
been elicited in men muscles if they have been
more physically active than women during their
daily life, and this issue has not been addressed in
the present investigation. Another mechanism that
could explain a greater Thr286CaMKII phosphoryl-
ation in men is the known antioxidant action of oes-
trogens (Vina & Borras, 2010). In agreement with
our results, CaMKII activity is significantly greater
in the heart of male rodents compared with females
(Konhilas et al., 2004). However, as we only
observed a tendency for a higher pCaMKII and
CnA levels in men, more studies are needed to deter-
mine a final significance.
Mortensen et al. (2009) examined AMPK activity
and expression in 91 young and older twins. In con-
cordance with our results, men had higher muscle α2
and γ3 AMPK mRNA subunits expression, and
Figure 3. (a) Relationships between the levels of basal Thr172AMPKα phosphorylation to total AMPKα (a.u.) and (a) MHC I; (b) MHC IIa;
(c) Pmax (W); and (D) Pmax (W/kg lean leg mass). In men (black dots) and women (white dots); significant regression lines (P < .05) are pre-
sented as dashed lines for the whole population, and solid lines for men.
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AMPKγ3 activity compared with women, under
resting conditions. The influence of sex on AMPKα
phosphorylation has been also studied in response
to submaximal endurance exercise, where α2
associated AMPK activation was higher in men
(Roepstorff et al., 2006). In contrast, after 30-s
sprint exercise, Thr172AMPKα phosphorylation was
increased similarly in men and women (Fuentes
et al., 2012).
In agreement with previous studies, men had a
higher percent of type IIa fibres and MHC IIa
(Richter & Ruderman, 2009; Roepstorff et al.,
2006). Greater basal AMPKα Thr172 phosphoryl-
ation has been reported in type IIa muscle fibres
from the vastus lateralis in five men using immuno-
fluorescence (Lee-Young, Canny, Myers, & McCo-
nell, 2009). Thus, in agreement with the
immunohistochemistry-based study of Lee-Young
et al. (2009), men had greater basal Thr172AMPK
phosphorylation than women, partly because men
had a higher proportion of type IIa fibres. However,
when only men were included in our statistical analy-
sis, basal AMPK phosphorylation was positively
associated with MHC I, which is reasonable, due to
the fact that muscle AMPK signalling governs fibre
switching to a more oxidative phenotype, in conjunc-
tion with PGC-1α, PPARδ, and SIRT1, among other
transcription factors (Steinberg & Jorgensen, 2007).
In accordance, pharmacologically activation of
AMPK has been associated with a shift from fibre
type b to IIa/x in rodents (Narkar et al., 2008). This
view is further supported by the fact that caloric
restriction increases basal Thr172AMPKα phos-
phorylation and fast to slow muscle fibre type tran-
sitions potentially acting through SIRT1 and PGC-
1α (Speakman & Mitchell, 2011). The observed
linear positive association between Thr172AMPKα
phosphorylation and MHC I in the present investi-
gation may seem at odds with the findings of Lee-
Young et al. (2009). This discrepancy may be due
to methodological differences (5 men and immuno-
histochemistry in Lee-Young et al. study and 25
men and Western blot in the present study). More-
over, Mortensen et al. (2009) observed significant
between-sex differences in AMPKγ3 mRNA,
protein levels, and activity after adjustment for
MHC mRNA proportions, indicating that sex differ-
ences in AMPKγ3 expression and activity are, at least
in part, independent of skeletal muscle fibre type
(Mortensen et al., 2009). It should be highlighted
that most AMPK heterotrimers contain the γ3
isoform in human skeletal muscle, implying that the
increased AMPKγ3 activity reported by this investi-
gation should account for most of the AMPKα
activity.
Mortensen et al. (2009) did not find any relation-
ship between AMPKα1 or α2 protein expression and
mRNA levels codifying the MHC isoforms. The
difference with the present investigation can be
explained because we measured MHC I, IIa, and IIx
protein expression, and not mRNA levels. The
linear relationships between MHC I, CaMKII, and
Thr172AMPKα phosphorylation levels in men
support the idea that the AMP/ATP ratio, free Ca2+,
and reactive oxygen and nitrogen species-mediated
signalling pathways are involved in the regulation of
muscle phenotype at the basal state under fasting
conditions.
In this investigation, we observed a linear relation-
ship between absolute peak power during the
Wingate test and lower extremities lean mass;
however, no associations were observed between
anaerobic performance and basal AMPK phos-
phorylation, and the levels of serum testosterone,
FT, and FAI in men. Thus, it seems that despite
the inhibitory effect of AMPK phosphorylation on
protein synthesis (Bolster, Crozier, Kimball, & Jeffer-
son, 2002), increased levels of basal AMPK phos-
phorylation do not appear to have a negative
influence on lean mass or sprint performance.
Although basal Thr172AMPKα phosphorylation
was associated with Wingate test peak power output,
this association was only statistically significant
when the whole group of subjects was analysed con-
jointly. This positive correlation could be due to the
fact that men had greater Thr172AMPKα phosphoryl-
ation than women, and not to AMPK-determined
skeletal muscle properties. In agreement, despite the
increased Thr172AMPKα phosphorylation in men,
no between-sex differences were observed in SIRT1
and PGC-1α protein content, two of the final molecu-
lar targets mediating muscle fibre swifts.
Conclusion
A marked twofold increase in basal AMPKα Thr172
phosphorylation is observed in men’s skeletal
muscle compared to women with no apparent associ-
ation with anaerobic performance. This study also
indicates that basal AMPK and CaMKII phosphoryl-
ation levels may be playing a role in the regulation of
skeletal muscle MHC I protein levels.
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